Several leading organizations worldwide focus on the manufacture of complex medicinal APIs, notably Abacavir Sulfate sulfate, Abarelix, and Abiraterone Mesylate. These substances present significant challenges in process development due to their molecular intricacy. The manufacturers of these APIs often employ sophisticated technologies and adhere